Celsius Stock Is Beaten Down Now, but It Could 10X

Source The Motley Fool

Celsius Holdings (NASDAQ: CELH) lost 70% of its value earlier this year. Its red-hot revenue growth suddenly turned negative as a key distributor, likely PepsiCo, dramatically pulled back on orders.

However, a closer analysis shows that the lower level of orders is probably an effort by the distributor to right-size its order quantities. Moreover, between a discounted valuation and a key untapped market, a 10x move in the stock might turn into a conservative estimate for gains. Here's why.

The current state of Celsius

Celsius has prospered under the leadership of CEO John Fieldly.

For one, Celsius emphasizes a health-based approach in its marketing, calling itself the "better-for-you, zero-sugar alternative" to the energy drinks of the past. Fieldly leveraged that difference to build a following among fitness enthusiasts.

Furthermore, Fieldly made a deal that supercharged its sales beginning in 2022 when Celsius signed a distribution deal with PepsiCo. This has dramatically increased sales, so much so that Celsius has become the third most popular energy drink in the U.S., lagging behind only Red Bull and Monster Beverage.

Energy Drink Market Share in the U.S., 2023

Data source: Statista.

Factors that could boost Celsius' stock price

Nonetheless, merely taking market share from Red Bull and Monster is unlikely to make the stock grow tenfold. Investors should also consider these two critical factors.

One is its valuation. Admittedly, Celsius' P/E ratio of 39 has fluctuated in recent years. However, it sells at a price-to-sales (P/S) ratio of 5. On average, it has traded at 15 times sales over the last five years, implying a 3x gain if it returns to that average level.

Even if the triple-digit sales growth and the higher sales multiples do not fully return, investors should look to its largely untapped potential abroad to take the stock to 10x growth. Fieldly has worked to make Celsius' energy drinks available in the Asia-Pacific region and Europe.

The financials show why this is necessary to continue its massive growth. In the first nine months of 2024, its sales of $1 billion grew by 5% annually, far below the 104% growth during the same time frame in the first three quarters of 2023. This includes a 31% year-over-year decline in Q3.

Although the U.S. and Canada account for less than 5% of the world's population, those countries made up 95% of Celsius' sales volume in the first nine months of the year. Additionally, sales outside its North America region (meaning the U.S. and Canada) increased by 36%. This shows that the current slowdown in revenue growth did not apply to its markets outside of North America.

This also indicates that its potential for selling in foreign markets is largely untapped. If the company can stoke international sales to the point where North America is under 50% of its sales volume, the company's revenue and profits (and likely its stock as well) should benefit from massive gains.

Buy Celsius stock

Investors should consider the pullback in Celsius stock a buying opportunity that could ultimately bring returns of 10x or more.

For one, it appears investors overreacted by allowing Celsius to fall by 70%. It is likely its distributor will right-size its inventory over time, meaning the considerable reduction in buying is unlikely to happen again.

Moreover, Celsius has just begun to sell its product to the 95% of the world's population outside of North America. If it can make its product significantly more popular in Europe or Asia, the company and its stock could benefit from outsized growth for years to come.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

  • Nvidia: if you invested $1,000 when we doubled down in 2009, you’d have $356,125!*
  • Apple: if you invested $1,000 when we doubled down in 2008, you’d have $46,959!*
  • Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $499,141!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of December 9, 2024

Will Healy has positions in Celsius. The Motley Fool has positions in and recommends Celsius and Monster Beverage. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Dogecoin Influencer Issues Critical Scam Alert To DOGE CommunityA Dogecoin (DOGE) influencer has sounded the alarm about a scam attack targeting members of the DOGE community. The influence has issued a critical warning about a new fraudulent social media account posing as the Dogecoin Foundation.
Author  Bitcoinist
Aug 20, 2024
A Dogecoin (DOGE) influencer has sounded the alarm about a scam attack targeting members of the DOGE community. The influence has issued a critical warning about a new fraudulent social media account posing as the Dogecoin Foundation.
placeholder
Japanese Yen weakens amid fading safe-haven demand after Trump delays tariffsThe Japanese Yen (JPY) drifts lower during the Asian session on Tuesday as US President Donald Trump's decision to delay plans to impose trade tariffs on Canada and Mexico dents demand for traditional safe-haven assets.
Author  FXStreet
Yesterday 02: 38
The Japanese Yen (JPY) drifts lower during the Asian session on Tuesday as US President Donald Trump's decision to delay plans to impose trade tariffs on Canada and Mexico dents demand for traditional safe-haven assets.
placeholder
Novo Nordisk Q4 2024 Results: Will Wegovy Continue to Shine?TradingKey - One of the biggest trends in the healthcare space over the past few years has been the rise of so-called GLP-1 drugs.These can help treat type 2 diabetes and obesity but one of the other
Author  TradingKey
Yesterday 02: 41
TradingKey - One of the biggest trends in the healthcare space over the past few years has been the rise of so-called GLP-1 drugs.These can help treat type 2 diabetes and obesity but one of the other
placeholder
US JOLTS job openings expected to decline slightly in DecemberThe Job Openings and Labor Turnover Survey (JOLTS) will be released on Tuesday by the United States (US) Bureau of Labor Statistics (BLS).
Author  FXStreet
22 hours ago
The Job Openings and Labor Turnover Survey (JOLTS) will be released on Tuesday by the United States (US) Bureau of Labor Statistics (BLS).
placeholder
Could We See Dogecoin And Shiba Inu Prices Continue to Rise As We Take A Look Into New Sensation RemittixThere were brief moments last week where it seemed possible that both Shiba Inu and Dogecoin might see sustained rises. This theory has been put to bed in the last 24 hours as things have taken a dramatic turn for the worse. Both assets have plummeted in value and continue to exhibit downward pressure. This […]
Author  Cryptopolitan
2 hours ago
There were brief moments last week where it seemed possible that both Shiba Inu and Dogecoin might see sustained rises. This theory has been put to bed in the last 24 hours as things have taken a dramatic turn for the worse. Both assets have plummeted in value and continue to exhibit downward pressure. This […]
goTop
quote